In a joint guidance document issued by the European Society for Paediatric Endocrinology and European Society of Endocrinology and published online in the European Journal of Endocrinology, ...

Few topics provoke as much concern as the perception that puberty is beginning earlier than ever. While synthetic ...

Ensera Design’s Maartje Pel discusses how medtech is embracing women-specific innovation to address historical gaps.

GoodRx (Nasdaq: GDRX), the leading platform for prescription savings in the U.S., today announced employer-sponsored access ...

MPLX (NYSE:MPLX) is pursuing growth projects in key basins while maintaining steady unit buybacks. The partnership is also ...

Many women are taking greater control of their reproductive timelines. Increasing numbers of women in their late 20s and early 30s are now exploring the egg freezing procedure ...

Currently, the American Red Cross is managing a severe blood shortage. Winter weather across the nation is causing disruptions and cancellations, which is why they need your help!

Supporting emotional well being is just as important as adjusting insulin doses.”— Dr. Erin Roe DALLAS, TX, UNITED ...

A conserved glucagon signaling pathway links high-fat diet-induced metabolic imbalance to cardiac arrhythmia through hormone-producing cells and heart-innervating neurons that regulate rhythmicity.

Loti Labs Pioneers Quality in GHRP-6 Research Tampa, United States - March 1, 2026 / Loti Labs / Loti Labs, a prominent ...

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Q4 2025 Earnings Call Transcript March 5, 2026 Lexicon Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.04, expectations were $-0.07.

Loti Labs produces GHRP-6 peptides to research-grade specifications, ensuring they meet the exact composition required for controlled and repeatable experimental outcomes. Each batch is meticulously ...